Published date 24/08/2015
Author Dr Özge Özkaya
We are delighted to announce the award of a new five-year lectureship position that will allow a promising young scientist to establish their own research group and build scientific capacity in Duchenne muscular dystrophy research. The award has been made to Dr Linda Popplewell from Royal Holloway University of London, who will develop new genetic therapies for Duchenne muscular dystrophy.
The award was made possible thanks to a generous donation from one of our supporters with an interest in long term investment into research for the advancement of treatments for Duchenne muscular dystrophy. Royal Holloway University of London is also contributing to the cost of the lectureship and marks a substantial increase in the University’s future capacity for further research to tackle the condition.
Dr Popplewell has been working with Professor George Dickson at Royal Holloway University of London for over 10 years where she has become an essential part of the research team. She also provides academic support for Professor Dickson, and is co-applicant for many research grant applications and co-supervisor for several PhD students.
Working in Professor Dickson’s laboratory, Dr Popplewell has been involved in the development of gene-based therapies for Duchenne muscular dystrophy, including exon skipping technology which is now being tested in clinical trials. She has also worked on developing a way of delivering a healthy dystrophin gene to muscles using a harmless virus. This wealth of expertise will be crucial for the successful completion of her ambitious research project. She aims to develop an innovative comprehensive therapy for Duchenne muscular dystrophy.
Dr Popplewell will be establishing herself as an independent researcher at Royal Holloway University of London, a highly regarded research institution, and will enjoy the support and mentorship of Professor Dickson, who said:
Linda is a highly skilled and independent researcher and an excellent teacher and mentor.